In neurodegenerative conditions like Alzheimer’s disease (AD), chronic inflammation plays a pivotal role in the disruption of the blood–brain barrier, primarily driven by signaling molecules such as TNFα and IL-1β. This evidence concerns the gene IL1B and Alzheimer disease.